March 30 (Reuters) - ECKERT & ZIEGLER STRAHLEN UND
MEDIZINTECHNIK AG EUZG.DE :
* FOR 2023 FINANCIAL YEAR, EXECUTIVE BOARD EXPECTS TO
ACHIEVE
REVENUES OF NEARLY EUR 230 MILLION IN OPERATING SEGMENTS -
MEDICAL AND ISOTOPES PRODUCTS - AND, AS IN 2022, A NET PROFIT OF
EUR 31 MILLION
* OUTLOOK 2023: NO REVENUES ARE EXPECTED IN OTHER SEGMENT
* OUTLOOK 2023: CONSOLIDATED NET INCOME (NET PROFIT) AS
TOTAL OF
ALL SEGMENTS WILL THEN AMOUNT TO AROUND EUR 25 MILLION
* WILL PROPOSE A DIVIDEND OF EUR 0.50 PER DIVIDEND-BEARING
SHARE
(PREVIOUS YEAR EUR 0.50)
Source text for Eikon: ID:nEQc8tr2qa
Further company coverage: EUZG.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))